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Abstract
DNA methylation is modifiable by acute and chronic exercise. DNA methyl-
transferases (DNMT) catalyze this process; however, there is a lack of litera-
ture concerning the specific mechanisms by which exercise-induced
modifications occur. Interleukin 6 (IL-6) stimulation of various cell lines has
been shown to augment DNMT expression and nuclear translocation, which
suggests a possible pathway by which exercise is able to elicit changes in
epigenetic enzymes. The present study sought to elucidate the response of the
de novo methyltransferases DNMT3A and DNMT3B to circulatory factors
found in plasma isolated from whole blood before and after 120-min of tread-
mill running at an intensity of 60% of individual velocity at _VO2max
(v _VO2max) interspersed with 30-sec sprints at 90% of v _VO2max every 10-min.
Peripheral blood mononuclear cells (PBMCs) isolated from a resting partici-
pant were incubated with plasma isolated from exercising participants
(n = 10) or recombinant IL-6 (rIL-6), followed by nuclear protein extraction
and quantification of DNMT3A and DNMT3B concentrations. Nuclear con-
centrations of DNMT3B significantly decreased following the experimental
protocol (P = 0.03), with no change observed in DNMT3A (P = 0.514).Vari-
ous concentrations of rIL-6 caused an elevation in both DNMT3A and
DNMT3B nuclear concentration compared with the blank control. The con-
flicting results between exercising and rIL-6 conditions suggests that IL-6 does
regulate DNMT nuclear transport, however, other plasma mediators may also
exert significant influence on the nuclear concentrations of these enzymes.
Introduction
Epigenetic modifications, such as DNA methylation and
histone tail methylation, acetylation, and phosphorylation,
are processes by which functional changes to DNA occur
independently from alterations to the nucleotide
sequence. DNA methylation is the most abundantly stud-
ied epigenetic modification, and is characterized by the
DNA methyltransferase (DNMT)-regulated addition of
a methyl group to the nucleotide cytosine creating
5-methylcytosine. This process occurs predominantly at
Cytosine-phosphate-Guanine (CpG) dinucleotides; cyto-
sine and guanine separated by a single phosphate bond
which are statistically underrepresented in the genome
(Lander et al. 2001). CpG islands, present in up to 72%
of gene promoter regions (Saxonov et al. 2006), are short
sequences, typically around 1000 base pairs long, and dif-
fer from usual genomic CpGs due to their low level or
complete absence of methylation (Deaton and Bird 2011).
Hypomethylation at these CpG-rich gene promoter
regions is often associated with active gene transcription.
Conversely, promoter region hypermethylation is usually
associated with transcriptional silencing, of which the
inhibition of transcription factor binding and the recruit-
ment of methyl-CpG binding proteins, which repress the
chromatin structure, are key mechanisms (Auclair and
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Weber 2012). A number of DNMTs regulate the methyla-
tion process; DNMT1 methylates hemimethylated DNA,
and therefore, has an important role with regard to the
maintenance of methylation through cell division.
DNMT3A and DNMT3B, on the other hand, show pref-
erence toward unmethylated CpG dinucleotides and are
both involved in de novo methylation. All three of these
DNMTs are essential in mammalian development, as
demonstrated by the death of DNMT-deficient mice
shortly after birth (Li 2002).
Exercise is known to promote a multitude of health
benefits, including decreased risk of cancer (Lee 2003),
cardiovascular disease (Thompson et al. 2003), and type 2
diabetes mellitus (Colberg et al. 2010); however, the
involvement of epigenetics in mediating these benefits
remains to be fully understood. The study of habitual
physical activity and long-term exercise interventions has
received some research attention in the context of epige-
netic modifications, with studies showing that chronic
exercise can alter the DNA methylome of various tissues,
including skeletal muscle, adipose tissue, leukocytes, and
sperm (Nitert et al. 2012; Rӧnn et al. 2013; Denham et al.
2015a,b). Unfortunately, however, there is a relative lack
of literature concerning the acute effect of exercise on
DNA methylation. Barres et al. (2012) reported that a
single _VO2peak test conducted on a cycle ergometer was
able to cause global hypomethylation of vastus lateralis
skeletal muscle in a cohort of sedentary young men and
women. They also assessed methylation of a number of
genes which are normally upregulated following an acute
exercise bout, using methylated DNA immunoprecipita-
tion and quantitative PCR. Hypomethylation occurred at
the peroxisome proliferator-activated receptor gamma
coactivator 1 alpha (PGC-1a), pyruvate dehydrogenase
lipoamide kinase isozyme 4 (PDK4), peroxisome prolifer-
ator-activated receptor delta (PPARd), transcription factor
A mitochondrial (TFAM), and citrate synthase (CS) gene
promoter regions, whereas the methylation status of mus-
cle-specific genes, myocyte-specific enhancer factor 2A
(MEF2A) and myogenic differentiation 1 (MYOD1),
remained unaltered. This suggests that the exercise-
induced upregulation (mRNA and protein level) of genes
involved in mitochondrial biogenesis and substrate
metabolism (Coffey and Hawley 2007) is due to epige-
netic modification. Given the aforementioned benefits
of regular physical activity and decreased disease risk,
exercise-induced gene promoter hypomethylation may be
a mechanism by which exercise exerts salubrious effects.
Furthermore, a recent study conducted by Robson-Ans-
ley et al. (2014) found that plasma interleukin-6 (IL-6)
may be linked with DNA methylation. The researchers
investigated the effect of a 120-min treadmill run at 60%
of v _VO2max interspersed with sprints at 90% of v _VO2max
for the last 30-sec of every 10-min (previously shown to
induce elevations in plasma IL-6; Walshe et al. 2010), fol-
lowed by a 5-km time trial, on subsequent changes in
DNA methylation of peripheral blood mononuclear cells
(PBMCs) as measured by the Infinium Human Methyla-
tion 27k beadchip (Illumina, San Diego, CA, USA).
Despite no significant change in global DNA methylation,
the exercise-induced increase in plasma IL-6 concentra-
tion was significantly correlated with the methylation sta-
tus of 11 genes (signaling lymphocytic activation
molecule 1 [SLAMF1], interleukin-1 receptor-associated
kinase 3 [IRAK3], LIM domain binding 2 [LDB2], trans-
membrane protein 156 [TMEM156], FC receptor-like 2
[FCRL2], cyclin-dependent kinase 9 [CDK9], signaling
threshold-regulating transmembrane adaptor 1 [SIT1],
EFG domain-specific O-linked N-acetylglucosamine trans-
ferase [AER61], recombination-activating gene 2 [RAG2],
phosphoseryl-TRNA kinase [C10orf89], CD40 ligand
[CD40LG]), a number of which are regulators of activities
involving B and T cells, while IRAK3 is a key inhibitor of
inflammation associated with the metabolic syndrome
and obesity. IL-6 likely modifies DNA methylation via
manipulation of DNMT expression and cellular transloca-
tion; in vitro IL-6 stimulation of K562 (human ery-
thromyeloblastoid leukemia) and A549 (human
adenocarcinomic alveolar basal epithelial) cells increased
DNMT1 expression via Janus kinase/Signal transducer
and activator of transcription (JAK2/STAT3) activation
(Hodge et al. 2001; Liu et al. 2015), while similarly,
Hodge et al. (2007) reported that augmented DNMT1
activity may be caused by protein kinase B (AKT)-depen-
dent phosphorylation of the DNMT1 nuclear localization
signal, thus allowing nuclear translocation, following
stimulation of HCT116 (human colorectal carcinoma)
cells with IL-6. As to whether IL-6 directly interacts with
DNMTs in PBMCs has yet to be reported however.
Many studies (Zhang et al. 2012; Shaw et al. 2014;
Denham et al. 2015b) have used blood leukocytes in
order to investigate CpG methylation in response to
habitual physical activity or exercise, as they may be use-
ful biomarkers of systemic changes (Denham et al.
2015b). However, considerable variation in methylation
exists between the various cell populations (Reinius et al.
2012), therefore, PBMCs not only represent a more
homogenous cell population than whole blood leukocytes,
but should also reflect systemic changes. Also, given that
aberrant DNA methylation in PBMCs is linked to various
cancers (Kitkumthorn et al. 2012; Friso et al. 2013; Gana-
pathi et al. 2014), schizophrenia (Auta et al. 2013), type 2
diabetes mellitus (Simar et al. 2014), Alzheimer’s disease
(Di Francesco et al. 2015), vitiligo (Zhao et al. 2010),
idiopathic thrombocytopenic purpura (Tao et al. 2008),
and rheumatoid arthritis (Nile et al. 2008), they appear to
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be a relatively noninvasive and inexpensive tissue, in
which exercise-induced epigenetic modifications may have
beneficial effects on disease pathogenesis.
The aim of the present study, therefore, was to charac-
terize potential changes in PBMC nuclear concentrations
of the de novo DNA methyltransferases DNMT3A and
DNMT3B caused by circulatory factors located in the
plasma following a protocol shown to elicit an acute,
transient increase in plasma IL-6. It was hypothesized that
nuclear concentrations of DNMT3B would be signifi-
cantly decreased following the exercise protocol, consis-
tent with results reported by Laye and Pedersen (2010).
Methods
Subjects
Ten recreationally active males were recruited from
Northumbria University to take part in the exercise trial.
Mean (standard deviation) characteristics are reported in
Table 1. Participants gave written informed consent, and
all methods were approved by the Northumbria Univer-
sity Ethics Committee. All PBMCs were isolated from a
resting, recreationally active participant who was recruited
under the same criteria as other participants. Further-
more, his characteristics fit within the standard deviation
of the exercising participants’ age, height, weight, and
BMI.
Experimental protocol
The following protocol has previously been reported else-
where (Walshe et al. 2010) and has been shown to elicit a
significant transient increase in plasma IL-6.
Familiarization
Participants first attended the laboratory in order to be
familiarized with the study protocol. This involved com-
pleting the full experimental protocol, as described below,
without blood samples being taken.
_VO2max assessment
Seven days after the initial familiarization, maximal oxy-
gen uptake ( _VO2max) was quantified using a motorized
treadmill (Pulsar, h/p/cosmos, Germany). Treadmill
speed was set to 12 km h1 on a 1% gradient and
increased by 1 km h1 every 3-min until the participant
reached volitional exhaustion. An online breath-by-breath
analyzer (Metalyzer 3B, Cortex, Germany) measured
expired gas, which was used to calculate running velocity
at v _VO2max. Heart rate was recorded via short-range
telemetry (Polar RS400, Finland) during the last 30-sec
of each stage. The test was considered maximal if two
of the following criteria were met: a heart rate greater
than 90% of the age predicted maximum (220 beats
min1  age), a change in _VO2max of less than 2 mL
kg1 min1 in the final two stages, or a respiratory
exchange ratio of 1.15 or greater.
Main trial
The main experimental trial was conducted following a
rest period of 7 days. Participants were instructed to
abstain from exercise, alcohol, and caffeine for the 24-h
period prior to testing. Participants arrived at 0900 fol-
lowing an overnight 12-h fast, during which they were
allowed to consume water ad libitum. Height and weight
were measured using standard procedures, and 22.5 mL
of blood was then collected into EDTA containing vacu-
tainers (Becton Dickinson, Oxford, UK) from a vein in
the antecubital fossa of the forearm. The main protocol
required participants to run at 60% of v _VO2max for
120-min, interspersed with sprints at 90% of v _VO2max for
the last 30-sec of every 10-min. Immediately upon com-
pletion of the run, a further blood sample was taken
using the same procedure as previously described. Pre-
and postrun blood samples were centrifuged at 1700 g for
10-min at 4°C in order for plasma to be separated. Sam-
ples were immediately stored at 80°C for later analysis.
Interleukin-6 assay
A QuantiGlo Human IL-6 ELISA (R&D Systems,
Minneapolis) was used in order to quantify pre- and
post-exercise plasma concentrations of IL-6 as per the
standard manufacturer’s guidelines. Samples were assayed
in duplicate, including positive controls and various dilu-
tions of the IL-6 standard which were used to plot a
standard curve. Assay sensitivity was 0.35 pgmL1, and
the assay detection range was between 0.480 and
1500 pgmL1. Intra-assay coefficient of variation was
calculated as 4.3%.
Table 1. Subject characteristics (n = 10).
Characteristic Mean (SD)
Age (years) 24 (3)
Height (cm) 178.5 (5.6)
Weight (kg) 77.5 (8.8)
Body mass index (kg m2) 24.3 (2.6)
_VO2max (mL kg
1 min1) 51.9 (6.7)
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Peripheral blood mononuclear cell viability
and nuclear protein extraction
In order to elucidate the role of circulatory factors found
in plasma, exercise-induced changes to the fractional cel-
lular composition of PBMC samples (Connolly et al.
2004) were controlled for by utilizing an identical cell
sample isolated from a single, resting participant in all
experimental conditions (described earlier). Furthermore,
the existence of single nucleotide polymorphisms of genes
involved in the DNA methylation cycle has led to the
assertion that there may be a genetic susceptibility to epi-
genetic modification (Terruzzi et al. 2011), thus, a single
set of cells is necessary to be able to isolate the specific
effects of exercise-conditioned plasma. Preliminarily,
PBMC viability following incubation with exercise-condi-
tioned plasma was calculated. Whole blood was collected
into six 10 mL lithium heparin vacutainer tubes (Becton
Dickinson, Oxford, UK). PBMCs were isolated using cen-
trifugation of a LeucoSep centrifuge tube (Greiner Bio-
One, Frickenhausen, Germany) containing Lymphoprep
(Stemcell Technologies, Vancouver, Canada). Following
counting of the cells, they were diluted accordingly in
order to yield 4 9 106 cells mL1. About 250 lL of
PBMCs (1 9 106 cells) were treated with 100 lL of either
pre-exercise plasma, post-exercise plasma, or fetal calf
serum (FCS), in addition to 150 lL of RPMI-1640 med-
ium and penicillin/streptomycin/glutamine solution
(Sigma Aldrich, Missouri), followed by incubation at
37°C for 4-h. Each condition was performed in triplicate.
Before and after incubation, the cells were mixed with
trypan blue solution (Sigma Aldrich, Missouri) in a 1:1
ratio, followed by 10 lL of the resultant solution being
pipetted into the upper chamber of an Improved Neu-
bauer cell counting chamber (Hawksley, Sussex, United
Kingdom). The number of live and dead cells was then
counted using a Nikon TMS-F inverted microscope
(Nikon, Tokyo, Japan).
In order to extract nuclear proteins, 250 lL of PBMCs
(1 9 106 cells) were treated with 100 lL of plasma sepa-
rated from whole blood of the exercising participants and
150 lL of RPMI-1640 medium and penicillin/strepto-
mycin/glutamine solution (Sigma Aldrich, Missouri), fol-
lowed by incubation at 37°C for 4-h. Separately, the same
volume and concentration of PBMCs were treated with
100 lL of FCS and various concentrations of recombinant
interleukin 6 (rIL-6): 0, 0.01, 0.1, 1, 10, and 100 ng mL1.
100 ng mL1 has previously been shown (Hodge et al.
2005; Foran et al. 2010) to increase DNMT1 expression in
a multiple myeloma cell line, while 10 ng mL1 was uti-
lized by Liu et al. (2015), who reported an increase in
DNMT1 expression in a lung cancer cell line. The lowest
concentration would be considered to be within the
expected physiological range following prolonged endur-
ance exercise. Nuclear protein extraction was then per-
formed as per the manufacturer’s guidelines (Episeeker
Nuclear Extraction Kit, Abcam, Cambridge, UK).
Bradford protein assay
Bradford assay was used to quantify the amount of protein
per lL of nuclear extract (Quick Start Bradford Protein
Assay, Bio Rad, California). The microplate was read at an
absorbance of 595 nm (Synergy HT, Bio Tek, Vermont).
The average blank value was subtracted from the sample
absorbance, and a standard curve was generated in order to
quantify protein amount for each nuclear extract.
DNMT quantification
Quantification of nuclear DNMT3A and DNMT3B enzyme
concentrations were performed as per the manufacturer’s
guidelines (Epiquik DNMT3A/B Assay Kit, Epigentek, New
York). All samples were assayed in duplicate, and various
dilutions of the respective DNMT standards were used to
plot a standard curve. Microplates were scanned at 450 nm
with a reference wavelength of 655 nm. Intra-assay coeffi-
cient of variations for DNMT3A and DNMT3B were calcu-
lated as 3.95% and 9.92%, respectively.
The following equation was used to quantify enzyme
concentration:
Concentrationðng mg of protein1Þ
¼ ðsample OD blank ODÞ=ðslope protein amountÞ
 1000
where OD is optical density/absorbance. Slope is gener-
ated from the standard curve. Protein amount (lg) as
quantified by Bradford assay.
Statistical analysis
Data were analyzed using IBM SPSS Statistics version 21.
Prior to performing parametric testing of the data, the
Shapiro–Wilk test of normality was utilized. Non-nor-
mally distributed data were subsequently log10 trans-
formed. Paired samples t-tests were used to test for
significance of repeated measures data. For independent
group analysis, Levene’s test was utilized in order to
ensure equality of variances, followed by independent
samples t-test. Mauchly’s test of sphericity and one-way
repeated measures ANOVA were used to analyze differ-
ences in nuclear DNMT concentrations following stimula-
tion with rIL-6. Statistical significance was set as P ≤ 0.05.
Sample size was calculated using a spreadsheet pub-
lished by Boston University/Boston Medical Center. At
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the time of planning of this study there had not been any
data published that reported changes in nuclear concen-
trations of DNA methyltransferase enzymes, and there-
fore, power calculations were based on initial findings
from our laboratory that showed that recombinant
human IL-6 was able to significantly augment nuclear
concentrations of these enzymes.
Results
Mean characteristics of the participants are provided in
Table 1. Mean body mass index shows that participants
were within the normal healthy range of less than
25 kg m2. Participants were defined as recreationally
active and showed a relatively high level of aerobic fitness,
reflected by a mean maximal oxygen consumption of
approximately 51.9 mL kg1 min1.
Peripheral blood mononuclear cell viability
Table 2 shows that in each condition, there was no statis-
tically significant difference in cell viability before and
after incubation for 4-h at 37°C.
Exercise-conditioned plasma cell stimulation
The effects of cell stimulation with plasma isolated follow-
ing 120-min of treadmill running, on subsequent changes
in nuclear concentrations of the de novo DNA methyl-
transferases DNMT3A and DNMT3B are illustrated visu-
ally in Figures 1 and 2. No change was observed in
nuclear concentration of DNMT3A following the exercise
stimulus, with mean (SD) “pre” and “post” concentra-
tions measured at 43.1 (8.7) and 41.5 (17.4) ng mg pro-
tein1, respectively (P = 0.736).
Conversely however, mean (SD) nuclear concentrations
of DNMT3B significantly decreased from 365.9 (363.6) to
87.2 (73.3) ng mg protein1 (P = 0.042) – an approximate
76% reduction immediately following the exercise bout.
Baseline concentrations of DNMT3B were significantly
higher than DNMT3A (P = 0.02), showing that DNMT3B
is more immediately abundant within PBMC nuclei.
Circulatory IL-6 concentration
Plasma concentrations of IL-6 were also quantified.
Figure 3 shows that mean (SD) systemic concentrations
significantly increased from 0.4 (0.3) to 14.9 (7.4) pgmL1
– a 35-fold increase “pre” to “post” exercise (P = 0.005).
Recombinant IL-6 cell stimulation
In order to isolate the possible effects of IL-6 on subse-
quent changes in DNMT3A and DNMT3B nuclear
concentrations, cells were also stimulated with various
concentrations of rIL-6 separately from exercise-condi-
tioned plasma. Results are represented in Table 3.
All concentrations of rIL-6 caused a significant increase
in nuclear DNMT3A concentration when compared with
the blank control (0.01, 0.1, 1, 10, and 100 ng mL1 con-
Table 2. Percentage of viable peripheral blood mononuclear cells
before and after incubation period.
Condition
Pre-incubation (%)
Mean (SD)
Post-exercise (%)
Mean (SD)
Pre-exercise plasma 99.2 (0.7) 98.1 (0.1)
Post-exercise plasma 98.7 (0.1) 96.9 (2.7)
Fetal calf serum 95.6 (1.5) 97.7 (2.0)
Figure 1. Mean (95% CI; min./max.) peripheral blood
mononuclear cell (PBMC) nuclear concentration of DNA
methyltransferase 3A (DNMT3A) following stimulation with pre-
and post-exercise plasma. A paired sample t-test was used to test
significance.
Figure 2. Mean (95% CI; min./max.) peripheral blood
mononuclear cell (PBMC) nuclear concentration of DNA
methyltransferase 3B (DNMT3B) following stimulation with pre- and
post-exercise plasma. A paired sample t-test was used to test
significance (*P < 0.05).
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centrations had P values of 0.041, 0.002, 0.033, 0.02, and
0.038, respectively), while 0.1 ng mL1 resulted in a sig-
nificantly greater DNMT3A concentration than
0.01 ng mL1 (P = 0.023). Despite the results visually
appearing to increase in a dose–response manner, no
other interactions passed the statistically significant
threshold of 0.05.
Nuclear DNMT3B concentrations were significantly
higher in 0.1, 10, and 100 ng mL1 conditions, compared
with the blank control (P = 0.032, 0.022, and 0.031, respec-
tively). Furthermore, the 10 ng mL1 condition caused a
significant augmentation when compared with 0.01, 0.1,
and 1 ng mL1 (P = 0.025, 0.018, 0.014, respectively).
Finally, mean DNMT3B concentration following
100 ng mL1 of rIL-6 was significantly greater than all
other rIL-6 conditions (P = 0.013, 0.031, 0.021, and 0.037,
respectively).
Discussion
This is the first study to investigate changes in the con-
centrations of the de novo DNA methyltransferases
DNMT3A and DNMT3B following stimulation of
PBMCs with plasma isolated before and after an acute
bout of intense treadmill exercise. While DNMT3A con-
centrations remained unaltered, a significant reduction
in the nuclear concentration of DNMT3B was observed
which is consistent with previous findings showing
decreased DNMT3B mRNA in vastus lateralis skeletal
muscle samples following exercise (Laye and Pedersen
2010). These data suggest that the two de novo methyl-
transferases have distinct roles in response to exercise,
and highlights a possible mechanism by which exercise
may be able to acutely alter levels of DNA methylation.
Furthermore, to our knowledge, no study has yet inves-
tigated the response of nuclear DNMT concentrations
in PBMCs following rIL-6 stimulation.
The significant increase in plasma IL-6 immediately fol-
lowing the exercise bout suggests that nuclear transport
or transcription of DNMT3A is unlikely to be solely regu-
lated by IL-6 mediated signaling pathways immediately
upon cessation of exercise, in contrast to the response of
DNMT3B. The posit that DNMT3A and DNMT3B pos-
sess diverse functions following an acute exercise stimulus
may be supported by findings which demonstrate that the
enzymes are differentially expressed during development;
DNMT3B is the primary active enzyme during earlier
embryonic stages such as implantation, whereas DNMT3A
expression is greater in the later stages of embryonic
development (Okano et al. 1999) and during methylation
of maturing gametes (Hara et al. 2014).
The observed decrease in nuclear concentration of
DNMT3B could be due to two mechanisms: downregula-
tion of gene transcription and/or enhanced nuclear
export. Laye and Pedersen (2010) reported a 50%
decrease in skeletal muscle DNMT3B mRNA following
3 h of cycling at 60% of _VO2max. Furthermore, ionomycin
(a Ca2+ ionophore) stimulation of differentiated myo-
tubes, but not proliferating myoblasts, caused attenuation
of both DNMT3A and DNMT3B mRNA by approxi-
mately 40%. The 75% decrease in nuclear concentration
of DNMT3B within the present study suggests nuclear
export of the enzymes may also be occurring concurrently
with transcriptional downregulation; 60-min of cycling
has previously been shown to significantly decrease
nuclear concentrations of the class IIa histone deacetylases
Figure 3. Mean (95% CI; min./max.) pre- and post-exercise
plasma concentrations of interleukin 6 (IL-6). A paired sample t-test
was used to test significance (*P < 0.05).
Table 3. Mean (SD) peripheral blood mononuclear cell (PBMC)
nuclear concentration of DNA methyltransferases 3A and 3B
(DNMT3A/DNMT3B) following stimulation with various concentra-
tions of recombinant interleukin 6 (rIL-6) (0, 0.01, 0.1, 1, 10, and
100 ng mL1).
rIL-6
concentration
(ng mL1)
Mean (SD)
Nuclear DNMT3A
Concentration
(ng mg protein1)
Mean (SD)
Nuclear DNMT3B
Concentration
(ng mg protein1)
0 3.3 (0.9) 32.8 (0.8)
0.01 28.9 (3.2)1 46.1 (16.7)
0.1 44.2 (1.1)12 88.8 (3.2)1
1 53.0 (4.5)1 90.9 (11.3)
10 60.3 (1.6)1 205.1 (7.7)1234
100 80.2 (5.7)1 458.7 (28.7)12345
A repeated measures ANOVA was used to test statistical
significance.
1Significantly greater than 0 (P < 0.05).
2Significantly greater than 0.01 (P < 0.05).
3Significantly greater than 0.1 (P < 0.05).
4Significantly greater than 1 (P < 0.05).
5Significantly greater than 10 (P < 0.05).
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HDAC4 and HDAC5 in skeletal muscle, possibly due to
enhanced nuclear export (McGee et al. 2009) via Ca2+/
calmodium-dependent protein kinase (CaMK) signaling
(McKinsey et al. 2000). Since skeletal muscle CaMKII
activity can be augmented by muscular contraction in an
intensity-dependent manner (Rose et al. 2006), when
combined with reported contraction-induced DNA
hypomethylation of mouse skeletal muscle (Barres et al.
2012; Lucas et al. 2012), this suggests a mechanistic link
between exercise, specifically muscular contraction, and
nuclear export of epigenetic enzymes. Whether epige-
netic signaling within peripheral blood cells is the same
as within muscle in response to exercise remains to be
elucidated.
If the observed decrease in nuclear concentration of
DNMT3B did indeed translate into DNA hypomethyla-
tion, this would be in contrast to the results reported by
Robson-Ansley et al. (2014), who found no differences in
global or gene-specific DNA methylation following an
identical protocol. However, the participants used by
Robson-Ansley et al. (2014) were trained, as opposed to
the recreationally active participants and cell donor uti-
lized within the present study. It is possible, therefore,
that endurance training-associated increases in CaMKII
(Rose et al. 2007) may attenuate the acute epigenetic
response to a further single exercise bout. Furthermore,
the Infinium Human Methylation 27k beadchip was uti-
lized in this study which only covers 27, 578 CpG sites
across 14, 495 genes, which may explain the lack of
detectable changes.
In contrast to the response of DNMT3A and DNMT3B
to acute exercise-conditioned plasma, following rIL-6
stimulation we observed an elevation of both DNMT3A
and DNMT3B nuclear concentrations. IL-6-induced AKT
phosphorylation of the DNMT1 nuclear localization sig-
nal, as previously reported by Hodge et al. (2007), may
explain the mechanistic link between IL-6 stimulation and
increased enzyme concentration within the nucleus.
Hodge et al. (2005) and Foran et al. (2010) both found
that stimulation of multiple myeloma or colorectal carci-
noma cell lines with the same concentration of rIL-6 as
utilized within the present study (100 ng mL1) resulted
in significant increases in DNMT1 mRNA. There was no
quantification of mRNA levels within our study however,
and therefore IL-6 induced transcriptional upregulation is
a speculative mechanism.
The conflicting outcomes between the exercise and rIL-
6 stimulation data suggest that molecules found in the
plasma other than IL-6 could have profound influences
on nuclear concentrations of DNMTs. Prostaglandin E2
(PGE2), a lipid autocoid derived from arachidonic acid, is
an important mediator in the acute inflammatory
response and can regulate IL-6 expression in various cell
types (Hinson et al. 1996; Williams and Shacter 1997;
Inoue et al. 2002; Bagga et al. 2003). Elevated plasma
PGE2 has previously been reported following a marathon
(Demers et al. 1981) and run to exhaustion at 80% of
VO2max (Venkatraman et al. 2001), therefore given the
intensity of the exercise bout in the present study, it is
possible that plasma PGE2 was elevated, contributing to
the augmentation of circulating IL-6. Furthermore,
expression of Sp1 and Sp3 transcription factors, known to
regulate DNMT3A (Jinawath et al. 2005), have been
shown to be upregulated following PGE2 stimulation,
concomitant with an increase in DNMT3A expression in
fibroblasts, and a decrease in DNMT3A and DNMT1
expression in RAW macrophages (Huang et al. 2012).
This not only demonstrates the role of PGE2 in regulation
of epigenetic regulatory enzymes, but also the specificity
of changes within different cell lines.
Circulating micro RNAs (miRNAs) are another candi-
date group of plasma molecules that could influence the
expression or transport of DNMTs. Changes in plasma
concentrations of a multitude of miRNAs have been
reported following acute aerobic (Nielsen et al. 2014),
resistance (Sawada et al. 2013), and eccentric (Banzet
et al. 2013) exercises. The role of IL-6 in the modification
of DNMT1 expression, which has been discussed else-
where within this article, could be mediated by miRNA-
148a and miRNA-152 (Braconi et al. 2010). Furthermore,
miRNA-143 has been shown to target DNMT3A (Ng
et al. 2009), and miRNA-148 targets the DNMT3B pro-
tein coding region (Duursma et al. 2008), while miRNA-
29 appears to be involved in the regulation of both
DNMT3A and DNMT3B (Fabbri et al. 2007; Garzon
et al. 2009; Takada et al. 2009).When combining these
data, it appears entirely possible that exercise-induced
changes to plasma miRNAs could have a profound influ-
ence on nuclear DNMT transport and/or gene expression
and warrants further investigation.
Limitations
A limitation of the present study was the lack of a direct
measure of genomic or gene-specific methylation, and
thus, it is not known whether the attenuation of
DNMT3B resulted directly in the modification of DNA
methylation. Hypo- or demethylation is known to occur
passively via downregulation of DNMT1, or actively via
upregulation of TET activity (Kohli and Zhang 2013);
however, the functional effects of a reduction in
DNMT3B are unknown.
The nonstatistically significant increases in nuclear
DNMT concentrations following stimulation of PBMCs
with rIL-6 are likely due to the low sample size; cells were
treated, incubated, and then assayed in duplicate. Visually,
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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there appears to be a dose–response relationship, however,
further investigation using larger sample sizes is required in
order to elucidate whether these increases in nuclear
DNMT concentration are genuine or anomalous.
An investigation into the distinct functions of DNMT3A
and DNMT3B is necessary in order to elucidate how the
enzymes are differentially regulated, and whether
DNMT3A exhibits a delayed response to exercise, similar
to the expression of the enzyme later in embryonic devel-
opment. Therefore, future research should look to sample
at multiple time points, and to perform further cell stimu-
lation studies with additional cytokines or compounds,
similar to the study conducted by Barres et al. (2012).
It must also be noted that due to the utilization of a
standardized cell sample from a single participant in all
experimental conditions, results may lack generalizability.
For example, the cell donor in the present study could be
a low or nonresponder due to their particular genotype,
possibly accounting for the lack of change in DNMT3A
concentration following stimulation with exercise-condi-
tioned plasma.
Conclusion
This study shows that circulatory factors found in the
plasma following a single bout of endurance exercise
are sufficient to decrease nuclear concentrations of
DNMT3B, which points to IL-6 as a contributor to exer-
cise-induced gene promoter hypomethylation, and thus
protein upregulation. The precise signaling molecules and
pathways involved in these modifications require much
elucidation; however, data suggest that IL-6 may only be
one of a number of mediators involved in the manipula-
tion of DNMT nuclear transport and gene expression.
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